{"component": "clause", "props": {"groups": [{"samples": [{"hash": "4bweqQ7whYR", "uri": "/contracts/4bweqQ7whYR#patent-certifications", "label": "Joint Venture Agreement (Hutchison China MediTech LTD)", "score": 30.4072551727, "published": true}, {"hash": "9GT7KCnQ9ta", "uri": "/contracts/9GT7KCnQ9ta#patent-certifications", "label": "Joint Venture Agreement (Hutchison China MediTech LTD)", "score": 30.3305950165, "published": true}, {"hash": "7gSRhi1GfMq", "uri": "/contracts/7gSRhi1GfMq#patent-certifications", "label": "Joint Venture Agreement (Hutchison China MediTech LTD)", "score": 26.8644771576, "published": true}], "snippet_links": [{"key": "each-party-will", "type": "clause", "offset": [0, 15]}, {"key": "notice-to-the", "type": "clause", "offset": [41, 54]}, {"key": "company-patent-rights", "type": "clause", "offset": [90, 111]}, {"key": "arise-from", "type": "definition", "offset": [169, 179]}, {"key": "sale-of", "type": "clause", "offset": [228, 235]}, {"key": "third-party-product", "type": "clause", "offset": [238, 257]}, {"key": "by-a-third-party", "type": "clause", "offset": [258, 274]}, {"key": "infringement-proceedings", "type": "clause", "offset": [312, 336]}, {"key": "the-third-party", "type": "definition", "offset": [345, 360]}, {"key": "with-respect-to", "type": "clause", "offset": [381, 396]}, {"key": "the-company-will", "type": "clause", "offset": [410, 426]}, {"key": "give-notice", "type": "definition", "offset": [427, 438]}, {"key": "notice-of", "type": "clause", "offset": [526, 535]}, {"key": "time-period", "type": "definition", "offset": [559, 570]}, {"key": "permitted-by-law", "type": "clause", "offset": [571, 587]}, {"key": "for-the-company", "type": "definition", "offset": [669, 684]}, {"key": "by-either-party", "type": "clause", "offset": [828, 843]}, {"key": "both-parties", "type": "definition", "offset": [876, 888]}, {"key": "required-by-law", "type": "clause", "offset": [900, 915]}, {"key": "the-party", "type": "clause", "offset": [935, 944]}, {"key": "necessary-for", "type": "definition", "offset": [994, 1007]}, {"key": "requested-by", "type": "clause", "offset": [1058, 1070]}], "size": 4, "snippet": "Each Party will immediately give written notice to the other if it becomes aware that any Company Patent Rights covering a Product are invalid or that infringement will arise from the manufacture, use, import, sale or offer for sale of a Third Party product by a Third Party. If the Company decides not to bring infringement proceedings against the Third Party making such a claim with respect to any Product, the Company will give notice to Nestl\u00e9 of its decision not to bring suit within [**] Business Days after receipt of notice of such claim (or, if the time period permitted by law is less than [**] Business Days, within half of the time period permitted by law for the Company to commence such action) and Nestl\u00e9 may then, but will not be obligated to, bring suit against the Third Party that filed such claim. Any suit by either Party may be in the name of either or both Parties, as may be required by law. For this purpose, the Party not bringing suit will execute such legal papers necessary for the prosecution of such suit as may be reasonably requested by the Party bringing suit.", "hash": "55631c18944aca8b62f9526f17cf3ab5", "id": 7}, {"samples": [{"hash": "eqnZ9J3EYT3", "uri": "/contracts/eqnZ9J3EYT3#patent-certifications", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "jkW1qUkbg5", "uri": "/contracts/jkW1qUkbg5#patent-certifications", "label": "License Agreement (Exelixis Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "notice-to-the", "type": "clause", "offset": [39, 52]}, {"key": "other-party", "type": "definition", "offset": [53, 64]}, {"key": "filed-pursuant-to", "type": "clause", "offset": [86, 103]}, {"key": "amendment-or", "type": "clause", "offset": [160, 172]}, {"key": "compound-patent", "type": "definition", "offset": [253, 268]}, {"key": "joint-patent-right", "type": "definition", "offset": [278, 296]}, {"key": "composition-of-matter", "type": "definition", "offset": [310, 331]}, {"key": "method-of-use", "type": "clause", "offset": [335, 348]}, {"key": "arise-from", "type": "definition", "offset": [426, 436]}, {"key": "a-third-party", "type": "clause", "offset": [437, 450]}, {"key": "licensed-activity", "type": "clause", "offset": [464, 481]}], "size": 8, "snippet": "Each Party shall promptly give written notice to the other Party of any certification filed pursuant to 21 U.S.C. \u00a7 355(b)(2)(A) or \u00a7 355(j)(2)(A)(vii) (or any amendment or successor statute thereto) of which it becomes aware claiming that any Licensed Compound Patent Right or Joint Patent Right Covering the composition of matter or method of use of any Licensed Compound or Product is invalid or that infringement will not arise from a Third Party conducting a Licensed Activity.", "hash": "36d54fafa0274ac579a0b42a81ac5d5f", "id": 1}, {"samples": [{"hash": "aW1DlbZUHMZ", "uri": "/contracts/aW1DlbZUHMZ#patent-certifications", "label": "Patent License Agreement", "score": 31.3408622742, "published": true}, {"hash": "82NBTiVcfev", "uri": "/contracts/82NBTiVcfev#patent-certifications", "label": "Patent License Agreement", "score": 31.3408622742, "published": true}, {"hash": "luhjNMblr7U", "uri": "/contracts/luhjNMblr7U#patent-certifications", "label": "Patent License Agreement (Aegerion Pharmaceuticals, Inc.)", "score": 21.6050643921, "published": true}], "snippet_links": [{"key": "copies-of", "type": "clause", "offset": [43, 52]}, {"key": "patent-invalidity", "type": "clause", "offset": [80, 97]}, {"key": "infringement-of", "type": "clause", "offset": [123, 138]}, {"key": "patent-right", "type": "definition", "offset": [146, 158]}, {"key": "pursuant-to-a", "type": "clause", "offset": [159, 172]}, {"key": "paragraph-iv", "type": "clause", "offset": [173, 185]}, {"key": "by-a-third-party", "type": "clause", "offset": [207, 223]}, {"key": "abbreviated-new-drug-application", "type": "definition", "offset": [234, 266]}, {"key": "foreign-equivalent", "type": "definition", "offset": [368, 386]}, {"key": "notification-and-copies", "type": "clause", "offset": [401, 424]}, {"key": "to-company", "type": "clause", "offset": [443, 453]}, {"key": "days-after", "type": "definition", "offset": [479, 489]}, {"key": "section-136", "type": "clause", "offset": [572, 584]}], "size": 6, "snippet": "Penn shall notify and provide Company with copies of any allegations of alleged patent invalidity, unenforceability or non-infringement of a Penn Patent Right pursuant to a Paragraph IV Patent Certification by a third party filing an Abbreviated New Drug Application, an application under \u00a7505(b)(2) or any other similar patent certification by a third party, and any foreign equivalent thereof. Such notification and copies shall be provided to Company within five (5) business days after Penn receives such certification, and shall be sent to the addresses specified in Section 13.6.", "hash": "dfedff100354efc9454f9d5b2b13fde4", "id": 2}, {"samples": [{"hash": "hpu9ye5ee5w", "uri": "/contracts/hpu9ye5ee5w#patent-certifications", "label": "License Agreement (Ironwood Pharmaceuticals Inc)", "score": 30.5797405243, "published": true}, {"hash": "4F45aJSmFzJ", "uri": "/contracts/4F45aJSmFzJ#patent-certifications", "label": "License Agreement", "score": 23.9322376251, "published": true}, {"hash": "5dzKfrgQyH3", "uri": "/contracts/5dzKfrgQyH3#patent-certifications", "label": "License Agreement (Ironwood Pharmaceuticals Inc)", "score": 21.0876121521, "published": true}], "snippet_links": [{"key": "each-party-will", "type": "clause", "offset": [0, 15]}, {"key": "notice-to-the", "type": "clause", "offset": [41, 54]}, {"key": "certification-of", "type": "clause", "offset": [68, 84]}, {"key": "filed-pursuant-to", "type": "clause", "offset": [117, 134]}, {"key": "foreign-equivalent", "type": "definition", "offset": [139, 157]}, {"key": "amendment-or", "type": "clause", "offset": [217, 229]}, {"key": "rights-licensed", "type": "clause", "offset": [289, 304]}, {"key": "other-party", "type": "definition", "offset": [312, 323]}, {"key": "arise-from", "type": "definition", "offset": [376, 386]}, {"key": "in-the-territory", "type": "clause", "offset": [416, 432]}, {"key": "third-party-product", "type": "clause", "offset": [441, 460]}, {"key": "by-a-third-party", "type": "clause", "offset": [461, 477]}, {"key": "infringement-proceedings", "type": "clause", "offset": [512, 536]}, {"key": "the-third-party", "type": "definition", "offset": [545, 560]}, {"key": "with-respect-to", "type": "clause", "offset": [589, 604]}, {"key": "give-notice", "type": "definition", "offset": [632, 643]}, {"key": "notice-of", "type": "clause", "offset": [732, 741]}, {"key": "time-period", "type": "definition", "offset": [773, 784]}, {"key": "permitted-by-law", "type": "clause", "offset": [785, 801]}, {"key": "the-certification", "type": "clause", "offset": [1018, 1035]}, {"key": "by-either-party", "type": "clause", "offset": [1046, 1061]}, {"key": "both-parties", "type": "definition", "offset": [1094, 1106]}, {"key": "required-by-law", "type": "clause", "offset": [1118, 1133]}, {"key": "the-party", "type": "clause", "offset": [1153, 1162]}, {"key": "necessary-for", "type": "definition", "offset": [1212, 1225]}, {"key": "requested-by", "type": "clause", "offset": [1276, 1288]}], "size": 6, "snippet": "Each Party will immediately give written notice to the other of any certification of which it becomes aware has been filed pursuant to any foreign equivalent to 21 U.S.C. \u00a7 355(b)(2)(A) or \u00a7 355(j)(2)(A)(vii) (or any amendment or successor statute thereto) claiming that any of its Patent Rights licensed to the other Party hereunder are invalid or that infringement will not arise from the manufacture, use or sale in the Territory of such Third Party product by a Third Party. If Astellas decides not to bring infringement proceedings against the Third Party making such a certification with respect to any Product, Astellas will give notice to Ironwood of its decision not to bring suit within ten Business Days after receipt of notice of such certification (or, if the time period permitted by law is less than 20 Business Days, within half of the time period permitted by law for Astellas to commence such action) and Ironwood may then, but will not be obligated to, bring suit against the Third Party that filed the certification. Any suit by either Party may be in the name of either or both Parties, as may be required by law. For this purpose, the Party not bringing suit will execute such legal papers necessary for the prosecution of such suit as may be reasonably requested by the Party bringing suit.", "hash": "66e5cb0ea4f66d59383744c131baf7c5", "id": 3}, {"samples": [{"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#patent-certifications", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#patent-certifications", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hPIwhY9xfY4", "uri": "/contracts/hPIwhY9xfY4#patent-certifications", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "notice-to-the", "type": "clause", "offset": [42, 55]}, {"key": "certification-of", "type": "clause", "offset": [69, 85]}, {"key": "filed-pursuant-to", "type": "clause", "offset": [109, 126]}, {"key": "amendment-or", "type": "clause", "offset": [195, 207]}, {"key": "regulatory-requirement", "type": "definition", "offset": [261, 283]}, {"key": "the-future", "type": "clause", "offset": [295, 305]}, {"key": "any-non", "type": "clause", "offset": [389, 396]}, {"key": "in-the-territory", "type": "clause", "offset": [410, 426]}, {"key": "joint-patent-right", "type": "definition", "offset": [443, 461]}, {"key": "licensed-product", "type": "clause", "offset": [519, 535]}, {"key": "arise-from", "type": "definition", "offset": [577, 587]}, {"key": "sale-of", "type": "clause", "offset": [612, 619]}, {"key": "by-a-third-party", "type": "clause", "offset": [630, 646]}, {"key": "receipt-of", "type": "clause", "offset": [667, 677]}, {"key": "first-right", "type": "clause", "offset": [712, 723]}, {"key": "the-obligation", "type": "clause", "offset": [733, 747]}, {"key": "prior-to-the", "type": "clause", "offset": [873, 885]}, {"key": "regulation-of", "type": "clause", "offset": [915, 928]}, {"key": "to-exercise", "type": "clause", "offset": [940, 951]}, {"key": "infringement-action-against-a-third-party", "type": "clause", "offset": [986, 1027]}, {"key": "the-provisions-of-section", "type": "clause", "offset": [1082, 1107]}], "size": 5, "snippet": "Each Party shall immediately give written notice to the other of any certification of which it becomes aware filed pursuant to 21 U.S.C. Section 355(b)(2)(A) or Section 355(j)(2)(A)(vii) (or any amendment or successor statute thereto), any similar statutory or regulatory requirement enacted in the future regarding biologic products, or any similar statutory or regulatory requirement in any non-U.S. country in the Territory claiming that a Joint Patent Right, Wyeth Patent Right or a Trubion Patent Right covering a Licensed Product is invalid or that infringement will not arise from the Manufacture, use or sale of a product by a Third Party. Upon the giving or receipt of such notice, Wyeth shall have the first right, but not the obligation, to bring an infringement action against such Third Party. In such a case, Wyeth shall notify Trubion at least ten (10) days prior to the date set forth by statute or regulation of its intent to exercise, or not exercise, this right. Any infringement action against a Third Party arising under this Section 6.2.4 shall be governed by the provisions of Section 6.2.2(b) hereof.", "hash": "9d49611e5152d0cf7af9b27b15de20f1", "id": 4}, {"samples": [{"hash": "g5TYfTvULRw", "uri": "/contracts/g5TYfTvULRw#patent-certifications", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.4072551727, "published": true}, {"hash": "idtJNVrIV8W", "uri": "/contracts/idtJNVrIV8W#patent-certifications", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.3305950165, "published": true}, {"hash": "dtcFeYHN9oB", "uri": "/contracts/dtcFeYHN9oB#patent-certifications", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 26.7878170013, "published": true}], "snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "notice-to-the", "type": "clause", "offset": [42, 55]}, {"key": "certification-of", "type": "clause", "offset": [69, 85]}, {"key": "filed-pursuant-to", "type": "clause", "offset": [118, 135]}, {"key": "amendment-or", "type": "clause", "offset": [192, 204]}, {"key": "other-jurisdiction", "type": "clause", "offset": [252, 270]}, {"key": "the-\u2587", "type": "clause", "offset": [285, 290]}, {"key": "joint-patent-rights", "type": "definition", "offset": [316, 335]}, {"key": "collaboration-product", "type": "clause", "offset": [347, 368]}, {"key": "arise-from", "type": "definition", "offset": [412, 422]}, {"key": "sale-of", "type": "clause", "offset": [470, 477]}, {"key": "third-party-product", "type": "clause", "offset": [483, 502]}, {"key": "by-a-third-party", "type": "clause", "offset": [503, 519]}, {"key": "the-right", "type": "clause", "offset": [544, 553]}, {"key": "first-instance", "type": "clause", "offset": [562, 576]}, {"key": "in-connection-with", "type": "clause", "offset": [609, 627]}, {"key": "infringement-proceedings", "type": "clause", "offset": [688, 712]}, {"key": "the-third-party", "type": "definition", "offset": [721, 736]}, {"key": "with-respect-to", "type": "clause", "offset": [765, 780]}, {"key": "give-notice", "type": "definition", "offset": [825, 836]}, {"key": "notice-of", "type": "clause", "offset": [927, 936]}, {"key": "time-period", "type": "definition", "offset": [968, 979]}, {"key": "permitted-by-law", "type": "clause", "offset": [980, 996]}, {"key": "the-certification", "type": "clause", "offset": [1220, 1237]}, {"key": "by-either-party", "type": "clause", "offset": [1248, 1263]}, {"key": "both-parties", "type": "definition", "offset": [1296, 1308]}, {"key": "required-by-law", "type": "clause", "offset": [1320, 1335]}, {"key": "the-party", "type": "clause", "offset": [1355, 1364]}, {"key": "necessary-for", "type": "definition", "offset": [1414, 1427]}, {"key": "requested-by", "type": "clause", "offset": [1478, 1490]}], "size": 5, "snippet": "Each Party shall immediately give written notice to the other of any certification of which it becomes aware has been filed pursuant to 21 U.S.C. \u00a7 355(b)(2)(A), or \u00a7 355(j)(2)(A)(vii) or any amendment or successor statute thereto or any analog in any other jurisdiction claiming that the \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Patent Rights or Joint Patent Rights covering a Collaboration Product are invalid or that infringement shall not arise from the manufacture, use, import sale or offer for sale of such Third Party product by a Third Party. AstraZeneca shall have the right, in the first instance, to commence an ANDA Proceeding in connection with any such certification. If AstraZeneca decides not to bring infringement proceedings against the Third Party making such a certification with respect to any Collaboration Product, AstraZeneca will give notice to \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 of its decision not to bring suit within [**] business days after receipt of notice of such certification (or, if the time period permitted by law is less than [**] business days, within half of the time period permitted by law for AstraZeneca to commence such action) and \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 may then, but shall not be obligated to, bring suit against the Third Party that filed the certification. Any suit by either Party may be in the name of either or both Parties, as may be required by law. For this purpose, the Party not bringing suit will execute such legal papers necessary for the prosecution of such suit as may be reasonably requested by the Party bringing suit.", "hash": "13ee3e035539e1da0e7f52f033502c51", "id": 5}, {"samples": [{"hash": "1wtegEHPVmM", "uri": "/contracts/1wtegEHPVmM#patent-certifications", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "4adQB8rOVsk", "uri": "/contracts/4adQB8rOVsk#patent-certifications", "label": "License Agreement (Syros Pharmaceuticals, Inc.)", "score": 27.4202594757, "published": true}, {"hash": "i1oqFBQZokd", "uri": "/contracts/i1oqFBQZokd#patent-certifications", "label": "License Agreement (Syros Pharmaceuticals, Inc.)", "score": 26.8836421967, "published": true}], "snippet_links": [{"key": "copies-of", "type": "clause", "offset": [57, 66]}, {"key": "patent-invalidity", "type": "clause", "offset": [94, 111]}, {"key": "infringement-of", "type": "clause", "offset": [137, 152]}, {"key": "patent-right", "type": "definition", "offset": [157, 169]}, {"key": "pursuant-to-a", "type": "clause", "offset": [170, 183]}, {"key": "paragraph-iv", "type": "clause", "offset": [184, 196]}, {"key": "by-a-third-party", "type": "clause", "offset": [218, 234]}, {"key": "abbreviated-new-drug-application", "type": "definition", "offset": [245, 277]}, {"key": "foreign-equivalent", "type": "definition", "offset": [379, 397]}, {"key": "notification-and-copies", "type": "clause", "offset": [412, 435]}, {"key": "to-company", "type": "clause", "offset": [454, 464]}, {"key": "days-after", "type": "definition", "offset": [486, 496]}], "size": 5, "snippet": "\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 and DFCI shall notify and provide COMPANY with copies of any allegations of alleged patent invalidity, unenforceability or non-infringement of any PATENT RIGHT pursuant to a Paragraph IV Patent Certification by a Third party filing an Abbreviated New Drug Application, an application under \u00a7505(b)(2) or any other similar patent certification by a third party, and any foreign equivalent thereof. Such notification and copies shall be provided to COMPANY within [**] business days after \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 and/or DFCI receive such certification.", "hash": "248d195739384d38f55238eab39608f3", "id": 6}, {"samples": [{"hash": "iM9xiHb4dzq", "uri": "/contracts/iM9xiHb4dzq#patent-certifications", "label": "Collaboration and License Agreement (Viropharma Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "patent-term-restoration", "type": "clause", "offset": [9, 32]}], "size": 4, "snippet": "63 8.2.5 Patent Term Restoration.................................................................................... 63 8.3 Trademarks.................................................................................................... 63 9. CONFIDENTIALITY..................................................................................................... 64", "hash": "0590df843702dc7e46b240efdbfc45f2", "id": 8}, {"samples": [{"hash": "azD1FxFoKZA", "uri": "/contracts/azD1FxFoKZA#patent-certifications", "label": "Development and License Agreement (Alpharma Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "to-the-extent", "type": "clause", "offset": [4, 17]}, {"key": "applicable-laws", "type": "clause", "offset": [43, 58]}, {"key": "commercially-reasonable-efforts", "type": "definition", "offset": [79, 110]}, {"key": "to-maintain", "type": "clause", "offset": [111, 122]}, {"key": "applicable-regulatory-authorities", "type": "definition", "offset": [132, 165]}, {"key": "in-the-territory", "type": "clause", "offset": [166, 182]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [183, 216]}, {"key": "correct-and-complete", "type": "definition", "offset": [217, 237]}, {"key": "applicable-patents", "type": "definition", "offset": [250, 268]}, {"key": "the-product", "type": "definition", "offset": [278, 289]}, {"key": "the-us", "type": "clause", "offset": [304, 311]}, {"key": "orange-book", "type": "definition", "offset": [329, 340]}, {"key": "the-\u2587", "type": "clause", "offset": [366, 371]}, {"key": "in-the-event", "type": "clause", "offset": [388, 400]}, {"key": "either-party", "type": "definition", "offset": [401, 413]}, {"key": "patent-certification", "type": "definition", "offset": [461, 481]}, {"key": "paragraph-iv-certification", "type": "definition", "offset": [543, 569]}, {"key": "section-31", "type": "definition", "offset": [651, 662]}, {"key": "such-party", "type": "clause", "offset": [669, 679]}, {"key": "notify-the", "type": "clause", "offset": [698, 708]}, {"key": "other-party", "type": "definition", "offset": [709, 720]}, {"key": "in-writing", "type": "definition", "offset": [721, 731]}, {"key": "first-right", "type": "clause", "offset": [776, 787]}, {"key": "notice-to", "type": "definition", "offset": [820, 829]}, {"key": "action-against", "type": "clause", "offset": [853, 867]}, {"key": "product-patent-rights", "type": "clause", "offset": [914, 935]}, {"key": "cause-of-action", "type": "definition", "offset": [1002, 1017]}, {"key": "in-good-faith", "type": "definition", "offset": [1114, 1127]}, {"key": "receipt-of", "type": "clause", "offset": [1202, 1212]}, {"key": "provided-that", "type": "clause", "offset": [1369, 1382]}, {"key": "subject-to-terms", "type": "clause", "offset": [1384, 1400]}, {"key": "section-93", "type": "clause", "offset": [1404, 1415]}, {"key": "sole-discretion", "type": "definition", "offset": [1444, 1459]}, {"key": "to-exercise", "type": "clause", "offset": [1474, 1485]}, {"key": "right-to", "type": "definition", "offset": [1496, 1504]}, {"key": "infringement-action", "type": "definition", "offset": [1529, 1548]}, {"key": "the-period", "type": "clause", "offset": [1748, 1758]}, {"key": "action-for-infringement-against", "type": "clause", "offset": [1801, 1832]}, {"key": "the-right", "type": "clause", "offset": [1874, 1883]}, {"key": "infringement-of-the", "type": "clause", "offset": [2178, 2197]}, {"key": "subject-to-the", "type": "clause", "offset": [3284, 3298]}, {"key": "prior-written-consent", "type": "clause", "offset": [3299, 3320]}, {"key": "the-applicable-terms", "type": "clause", "offset": [3374, 3394]}, {"key": "relating-to", "type": "definition", "offset": [3413, 3424]}, {"key": "entered-into", "type": "clause", "offset": [3434, 3446]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [3457, 3484]}, {"key": "terms-of-the", "type": "clause", "offset": [3576, 3588]}, {"key": "costs-of", "type": "clause", "offset": [3613, 3621]}, {"key": "fees-of-attorneys", "type": "clause", "offset": [3672, 3689]}, {"key": "other-professionals", "type": "definition", "offset": [3694, 3713]}, {"key": "the-party", "type": "clause", "offset": [3733, 3742]}, {"key": "the-action", "type": "clause", "offset": [3755, 3765]}, {"key": "by-the-parties", "type": "clause", "offset": [3875, 3889]}, {"key": "action-to-terminate", "type": "clause", "offset": [3953, 3972]}, {"key": "all-documents", "type": "clause", "offset": [4260, 4273]}, {"key": "necessary-for", "type": "definition", "offset": [4274, 4287]}, {"key": "enforcing-party", "type": "definition", "offset": [4292, 4307]}, {"key": "each-party", "type": "clause", "offset": [4346, 4356]}, {"key": "infringement-proceedings", "type": "clause", "offset": [4423, 4447]}, {"key": "reasonable-assistance", "type": "definition", "offset": [4453, 4474]}, {"key": "reasonably-request", "type": "definition", "offset": [4512, 4530]}, {"key": "any-settlement", "type": "clause", "offset": [4589, 4603]}, {"key": "consent-judgment", "type": "definition", "offset": [4605, 4621]}, {"key": "disposition-of", "type": "clause", "offset": [4647, 4661]}, {"key": "invalidity-or-unenforceability", "type": "clause", "offset": [4690, 4720]}, {"key": "monetary-payment", "type": "definition", "offset": [4837, 4853]}, {"key": "consent-of-the", "type": "clause", "offset": [4880, 4894]}, {"key": "the-proceedings", "type": "definition", "offset": [5146, 5161]}, {"key": "by-a-third-party", "type": "clause", "offset": [5178, 5194]}, {"key": "in-the-same-manner", "type": "definition", "offset": [5301, 5319]}, {"key": "section-94", "type": "clause", "offset": [5335, 5346]}], "size": 4, "snippet": "(a) To the extent required or permitted by Applicable Laws, [**] shall use its Commercially Reasonable Efforts to maintain with the applicable Regulatory Authorities in the Territory during the Term of this Agreement correct and complete listings of applicable Patents covering the Product, including in the U.S., all so called \u201cOrange Book\u201d listings required under the \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587 Act. In the event either Party receives notice that a Third Party has filed a patent certification under the \u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587 Act or any successor statute (e.g., a Paragraph IV Certification under 21 C.F.R. \u00a7314.50(i) or 314.94(a)(12)) referencing a Patent licensed under Section 3.1, then such Party shall immediately notify the other Party in writing of such notice.\n(b) Alpharma shall have the first right, but not the duty, upon written notice to Durect to institute an action against such Third Party alleging infringement of any Product Patent Rights, and to the extent necessary, Durect shall assign to Alpharma its cause of action for infringement of any Product Patent Rights against such Third Party. Alpharma shall consider in good faith all comments provided by Durect within the [**] period following Durect\u2019s receipt of such notice from Alpharma regarding Alpharma\u2019s intention to initiate an action against such Third Party alleging infringement of any Product Patent Rights; provided that, subject to terms of Section 9.3(d), Alpharma shall have the sole discretion and authority to exercise its first right to institute such a patent infringement action. If Alpharma determines not to institute an action against such Third Party alleging infringement of any Product Patent Rights, Alpharma shall so notify Durect at least [**] before the expiration of the period within which a patent holder may bring an action for infringement against such Third Party. Durect shall then have the right, but not the duty, to institute such an action against such Third Party alleging infringement of any Product Patent Rights.\n(c) As between Durect and Alpharma, Durect shall have the first right, but not the duty, upon written notice to Alpharma to institute an action against a Third Party for infringement of the [**] in response to such Third Party\u2019s filing of a Paragraph IV certification referencing such Patent rights. Durect shall consider in good faith all comments provided by Alpharma within the [**] period following Alpharma\u2019s receipt of such notice from Durect regarding Durect\u2019s intention to initiate an action against such Third Party alleging infringement of the [**]; provided that, subject to terms of Section 9.3(d), Durect shall have the sole discretion and authority to exercise its first right to institute such a patent infringement action. If Durect determines not to institute an action against such Third Party alleging infringement of the [**], Durect shall so notify Alpharma at least [**] before the expiration of the period within which a patent holder may bring an action for infringement against such Third Party. Alpharma shall then have the right, but not the duty, to institute such an action against such Third Party alleging infringement of the [**]; provided, however, that Alpharma\u2019s right to undertake any such action alleging infringement of the [**] shall be subject to the prior written consent of Durect, not to be unreasonably withheld, and also the applicable terms of any agreements relating to the [**] entered into by Durect prior to the Effective Date, and with respect any actions alleging infringement of the [**], subject to the applicable terms of the [**] Agreement.\n(d) The Costs of any such action under this Section 9.3 (including fees of attorneys and other professionals) shall be borne by the Party instituting the action, or, if the Parties elect to cooperate in instituting and maintaining such action, such Costs shall be borne by the Parties in such proportions as they may agree in writing. For any such action to terminate any such infringement, in the event that either Party is unable to initiate or prosecute such action solely in its own name or it is otherwise advisable to obtain an effective remedy, the other Party will join such action voluntarily and will execute and cause its Affiliates to execute all documents necessary for the enforcing Party to initiate and maintain such action. Each Party shall at its own expense promptly give to the Party bringing such infringement proceedings such reasonable assistance as the Party bringing the action may reasonably request. The Party instituting any such action may not enter into any settlement, consent judgment or other voluntary final disposition of such action that admits the invalidity or unenforceability of any Patent licensed hereunder, subjects the other Party to an injunction or requires the other Party to make any monetary payment without the prior written consent of the other Party, not to be unreasonably withheld by the other Party. The Party undertaking any proceedings shall keep the other reasonably informed of the progress of the action and shall consider the comments and observations of the other in prosecuting the proceedings. Any award paid by a Third Party as a result of such an infringement action (whether by way of settlement or otherwise) shall be allocated in the same manner as provided in Section 9.4.", "hash": "50ce5a47fb038305ba92b6e6d89fbde4", "id": 9}, {"samples": [{"hash": "cJVKAXMrwC8", "uri": "/contracts/cJVKAXMrwC8#patent-certifications", "label": "License Agreement (Codiak BioSciences, Inc.)", "score": 31.6885700226, "published": true}, {"hash": "k9vo7XiMVsQ", "uri": "/contracts/k9vo7XiMVsQ#patent-certifications", "label": "License Agreement (Codiak BioSciences, Inc.)", "score": 30.3223819733, "published": true}, {"hash": "7LHTW2aO5WT", "uri": "/contracts/7LHTW2aO5WT#patent-certifications", "label": "License Agreement (Codiak BioSciences, Inc.)", "score": 30.1745376587, "published": true}], "snippet_links": [{"key": "copies-of", "type": "clause", "offset": [43, 52]}, {"key": "patent-invalidity", "type": "clause", "offset": [80, 97]}, {"key": "infringement-of", "type": "clause", "offset": [123, 138]}, {"key": "licensed-patent", "type": "definition", "offset": [141, 156]}, {"key": "pursuant-to-a", "type": "clause", "offset": [157, 170]}, {"key": "paragraph-iv", "type": "clause", "offset": [171, 183]}, {"key": "by-a-third-party", "type": "clause", "offset": [205, 221]}, {"key": "abbreviated-new-drug-application", "type": "definition", "offset": [232, 264]}, {"key": "foreign-equivalent", "type": "definition", "offset": [366, 384]}, {"key": "notification-and-copies", "type": "clause", "offset": [399, 422]}, {"key": "days-after", "type": "definition", "offset": [473, 483]}], "size": 3, "snippet": "Kayla shall notify and provide Codiak with copies of any allegations of alleged patent invalidity, unenforceability or non-infringement of a Licensed Patent pursuant to a Paragraph IV Patent Certification by a Third Party filing an Abbreviated New Drug Application, an application under \u00a7505(b)(2) or any other similar patent certification by a Third Party, and any foreign equivalent thereof. Such notification and copies shall be provided to Codiak within [***] business days after Kayla receives such certification.", "hash": "f69488df724634b4cf82589a884d01d3", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih5wYXRlbnQtY2VydGlmaWNhdGlvbnMjMDAwMDAwMGEMogECZW4YACAA", "clause": {"parents": [["intellectual-property", "Intellectual Property"], ["infringement", "Infringement"], ["patent-rights", "Patent Rights"], ["miscellaneous", "Miscellaneous"], ["interest", "Interest"]], "children": [["\u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587-act", "\u2587\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587\u2587\u2587 Act"], ["orange-book-listings", "Orange Book Listings"], ["notice-actions", "Notice; Actions"], ["regulatory-listings", "Regulatory Listings"], ["permitted-use-and-disclosures", "Permitted Use and Disclosures"]], "size": 89, "title": "Patent Certifications", "id": "patent-certifications", "related": [["debarment-certifications", "DEBARMENT CERTIFICATIONS", "DEBARMENT CERTIFICATIONS"], ["debarment-certification", "Debarment Certification", "Debarment Certification"], ["exhibit-d-debarment-certification", "Exhibit D - Debarment Certification", "Exhibit D - Debarment Certification"], ["child-support-certification", "CHILD SUPPORT CERTIFICATION", "CHILD SUPPORT CERTIFICATION"], ["medical-certification", "Medical Certification", "Medical Certification"]], "related_snippets": [], "updated": "2025-11-06T04:31:31+00:00", "also_ask": ["What are the essential elements that must be included in a robust patent certification clause?", "How can this clause be strategically negotiated to allocate patent infringement risks?", "What are the most common pitfalls or fatal flaws in patent certification drafting?", "How do patent certification requirements differ across key jurisdictions?", "What standards do courts apply to determine the enforceability of patent certification clauses?"], "drafting_tip": "Specify required patent certifications, detail timing for submission, and outline consequences for non-compliance to ensure clarity, timely compliance, and enforceability.", "explanation": "A Patent Certifications clause requires one or both parties to formally declare the status of any patents relevant to the subject matter of the agreement. Typically, this involves certifying that the products, services, or processes being provided do not infringe on third-party patents, or that the party holds the necessary rights to use any patented technology involved. This clause helps prevent future disputes over intellectual property by ensuring that all parties are aware of and have addressed potential patent issues before entering into the agreement."}, "json": true, "cursor": ""}}